Jim Cramer backs Astera Labs, rejects Rigetti in lightning round

The “Mad Money” host said Astera Labs remains a buy despite sentiment pressure, while offering no endorsement for Rigetti Computing or MakeMyTrip and reaffirming his long-term stance on Eli Lilly.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.